JOHNSON&JOHN 20/40JOHNSON&JOHN 20/40JOHNSON&JOHN 20/40

JOHNSON&JOHN 20/40

No trades
See on Supercharts

US478160CR3 analysis



Key facts


Issue date
Aug 25, 2020
Maturity date
Sep 1, 2040
Outstanding amount
‪1.00 B‬USD
Face value
1,000.00USD
Minimum denomination
2,000.00USD
Coupon
2.10% (Fixed)
Yield to maturity
6.06%
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.